1149 Sensitizing aggressive murine pancreatic cancer to immune checkpoint blockade using a tumor-targeted, STING agonist ‘payloaded’ antibody

• Michael Curran,
• Sean Smith,
• Akash Boda,
• Shweta Hegde

Affiliations

Michael Curran

Aff7 0000 0001 2291 4776grid.240145.6Department of Investigational Cancer TherapeuticsThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Unit 0455 77030 Houston TX USA

Sean Smith

2Silverback Therapeutics, Seattle, WA, USA

Akash Boda

1 Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Shweta Hegde

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA